Patients initiating GLP-1 therapy for weight management should anticipate a gradual titration schedule designed to minimize adverse effects while optimizing therapeutic response
GLP-1 drugs can reduce appetite, so certain individuals consume less food and could be undernourished
You Have a BMI of 30 or Higher The FDA has approved GLP-1 medications for individuals with a BMI (Body Mass Index) of 30 or higher, which is classified as obese
Crohn's Disease: Symptoms and Current Treatments Crohn's disease is a chronic, relapsing inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract, from the mouth to the anus, though it most commonly involves the terminal ileum and colon
Injectable methylcobalamin dosing Injectable b12 provides the most reliable absorption
In terms of convenience, tablets provide a needle-free option for those comfortable with daily medication schedules, while injections minimize dosing frequency